General Information of the Compound
| Compound ID |
CP0076946
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(alpha-methyl-1-adamantyl)methylamine
Show/Hide
|
||||||||||||||||||
| Synonyms |
1-(1-Adamantyl)ethanamine
1-(1-Adamantyl)ethylamin
1-(1-adamantyl)-ethylamine
1-(1-adamantyl)ethylamine
1-(adamantan-1-yl)ethan-1-amine
1-(tricyclo[3.3.1.1~3,7~]dec-1-yl)ethanamine
1-Adamantan-1-yl-ethylamine
1-Adamantan-1-ylethylamine
1-tricyclo[3.3.1.1~3,7~]dec-1-ylethanamine
Alpha-Methyl-1-adamantanemethylamine
Alpha-Methyladamantanemethylamine
BRN 2715740
CHEMBL959
Enamine_005755
Flumadine (TN)
HSDB 7438
RIMANTADIN
Remantadine
Riamantadine
Rimant
Rimant & .alpha. IFN
Rimantadina
Rimantadina [INN-Spanish]
Rimantadine
Rimantadine (INN)
Rimantadine [INN:BAN]
Rimantadinum
Rimantadinum [INN-Latin]
Rimantidine & .alpha.IFN
Tricyclo(3.3.1.1^3,7)decane-1-methanamine, .alpha.-methyl-& IFN.alpha
alpha-Methyladamantanemethylamine
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C12H21N
|
||||||||||||||||||
| Molecular Weight |
179.307
|
||||||||||||||||||
| Canonical SMILES |
CC(N)C12CC3CC(CC(C3)C1)C2
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C12H21N/c1-8(13)12-5-9-2-10(6-12)4-11(3-9)7-12/h8-11H,2-7,13H2,1H3
Show/Hide
|
||||||||||||||||||
| InChIKey |
UBCHPRBFMUDMNC-UHFFFAOYSA-N
|
||||||||||||||||||
| CAS |
13392-28-4
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT05367, Multidrug and toxin extrusion protein 1
Protein ID: PT01174, Polymerase acidic protein
Protein ID: PT04591, Solute carrier family 22 member 2
Cell Viability or Cytotoxicity Assay
| Cell Line ID | Cell Line Name | Cell Line Organism | |
| CL000031 | MDCK | Canis lupus familiaris (Dog) | 1 |
| 1 |
CC50 = 62000 nM
|
TI
LI
LO
TS
|
|
|---|---|---|---|
Clinical Information about the Compound
Drug 1 ( Rimantadine )
| Drug Name | Rimantadine | ||
|---|---|---|---|
| Company | Forest Laboratories Inc | ||
| Indication | |||
| Target(s) | |||